Results 1 to 10 of about 7,404 (210)

Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy [PDF]

open access: yesObstetrics & Gynecology Science
Significant progress has been made in the molecular diagnosis of cancer. It provides personalized medicine, including cancer diagnosis, prognosis, targeted therapy, and risk detection.
Jihye Kim, Chel Hun Choi
doaj   +4 more sources

Transvaginal laparoscopic salpingo-oophorectomy: an oncological risk-reducing procedure [PDF]

open access: yesFuture Science OA, 2020
Aim: Since the first natural orifice transluminal endoscopic surgery procedure, renewed interest has arisen in further developing and advancing minimal access surgery.
Kostas Lathouras   +6 more
doaj   +3 more sources

Risk-reducing salpingo-oophorectomy for hereditary ovarian cancer [PDF]

open access: yesZhongguo aizheng zazhi, 2022
Ovarian cancer is one of the most common and lethal diseases among females. Due to the difficulty of surveillance and early detection, most ovarian cancers were diagnosed at advanced stage with poor outcomes.
FENG Zheng, WEN Hao
doaj   +2 more sources

Bone density loss after risk reducing salpingo-oophorectomy [PDF]

open access: yesHereditary Cancer in Clinical Practice, 2012
Women undergoing risk-reducing salpingo-oophorectomy through the Prince of Wales Hospital Hereditary Cancer Clinic are offered enrolment in a prospective study of bone mineral density (BMD), markers of bone metabolism and cardio-vascular risk factors. Participants are invited to enroll a friend who has ovaries in situ and are aged within five years of ...
Andrews L, Zielony B, White C
doaj   +2 more sources

Risk-reducing Salpingo-oophorectomy consults and practices during the COVID-19 pandemic [PDF]

open access: yesGynecologic Oncology Reports, 2022
Objective: Investigate the impact of the COVID-19 pandemic on risk-reducing salpingo-oophorectomies (RRSO) consults. Methods: Survey sent out to 1,127 full members of the Society of Gynecologic Oncology in August 2021.
A.E. O'Mara   +4 more
doaj   +2 more sources

Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy [PDF]

open access: yesEuropean Journal of Medical Research, 2019
Background Growing demand for risk-reducing surgery in individuals with inherited susceptibility to cancer leads to the question whether these procedures are cost effective for the executing hospitals. This study compared the clinical costs for bilateral
Michael G. Schrauder   +9 more
doaj   +3 more sources

Risk factors for weight gain after risk reducing salpingo-oophorectomy in premenopausal patients with hereditary ovarian cancer risk [PDF]

open access: yesGynecologic Oncology Reports
Introduction: This study examines weight changes in premenopausal patients following risk-reducing salpingo-oophorectomy (RRSO) and factors associated with postoperative weight gain.
Surabhi Tewari   +6 more
doaj   +2 more sources

Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy [PDF]

open access: yesSexual Medicine, 2018
Introduction: Women after risk-reducing salpingo-oophorectomy (RRSO) can have impaired sexual functioning, but whether there is an association between hormone levels and sexual functioning is unclear.
Nora Johansen, MD   +3 more
doaj   +3 more sources

Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer [PDF]

open access: yesJournal of Ovarian Research, 2023
Background Risk-reducing salpingo-oophorectomy (RRSO) is recommended for women at increased risk of breast and ovarian cancer. We launched a prospective study of women receiving RRSO, including those with mutations in genes beyond BRCA1/2.
Zheng Feng   +7 more
doaj   +2 more sources

Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan [PDF]

open access: yesArchives of Public Health, 2023
Background In April 2020, insurance coverage for risk-reducing salpingo-oophorectomy (RRSO) for breast cancer patients with hereditary breast and ovarian cancer (HBOC) syndrome and BRCA testing were started in Japan.
Katsuyuki Konnai   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy